EU backs development of molecular Dx test for malaria

09/25/2013 | GenomeWeb Daily News (free registration)

Forsite Diagnostics will use a $728,438 grant from the European Commission to support the development of a molecular test to diagnose malaria quickly. The company is developing the blood-based assay for use in detecting Plasmodium falciparum or Plasmodium vivaxis parasites, which trigger malaria, to help doctors prescribe appropriate treatments immediately.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR